NCT01517126

Brief Summary

Background: \- Currently, there is no standard method to study suicide risk in youth with developmental delays or intellectual disabilities (DD/ID). Youth with DD/ID are often excluded from studies that are used to develop these methods. As a result, most current suicide risk assessments have not been tested for use with people with DD/ID. Researchers want to develop an effective suicide risk screening tool for children and adolescents with DD/ID. Objectives: \- To develop a suicide risk screening tool for young adults with DD/ID. Eligibility:

  • Young adults between 12 and 21 years of age who have DD/ID and are in mental health counseling.
  • Participants will be in counseling at Surrey Place Centre, a community health center in Toronto, Canada. Design:
  • Participants will fill out questionnaires during a 1-hour meeting with a therapist. The questions will ask about mood and current feelings, including whether the participant has been thinking about or planning to hurt or kill him or herself now or in the past. Other questions will ask about participants' understanding of death in general.
  • Parents of participants may also fill out a questionnaire. It will ask about how the participant has been feeling. It will also ask whether the parent has noticed any signs that suggest suicidal thoughts or actions, now and in the past.
  • Treatment will not be provided as part of this protocol. However, participants can receive counseling through the regular Surrey Place Centre services.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 6, 2012

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

January 24, 2012

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 25, 2012

Completed
7.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 13, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 13, 2019

Completed
Last Updated

September 18, 2019

Status Verified

September 1, 2019

Enrollment Period

7.7 years

First QC Date

January 24, 2012

Last Update Submit

September 17, 2019

Conditions

Keywords

Youth SuicideSuicide ScreeningDevelopmental DelayIntellectual DisabilityAssessment InstrumentMental RetardationSuicidal ThoughtsSuicidal Behavior

Eligibility Criteria

Age12 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Client must be enrolled in individual counseling at the Surrey Center at time of participation and must have attended at least 3 therapy appointments.
  • Clients must have an IQ score betwen 55 and 75 (a range considered to "mild developmental delay"). A client with mild DD will have the ability to communicate verbally and provide writtent assent. In order to receive services at Surrey Place Centre, clients must have a designation of "developmental delay" with and IQ score or range. If they do not have an IQ Score or DD designation, they undergo assessment at intake. Therefore, each client will have an IQ score recorded prior to study recruitment.
  • Age 12 years or older
  • English speaking
  • A legal guardian must provide informed consent and client must sign an assent document. Verbal assent is not acceptable for participation.

You may not qualify if:

  • Legal guradian is non-English speaking and no translation support is available to assist with the consent process.
  • No IQ score on record.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Surrey Place Centre

Toronto, Canada

Location

MeSH Terms

Conditions

Child Development Disorders, PervasiveLearning DisabilitiesIntellectual DisabilitySuicidal Ideation

Condition Hierarchy (Ancestors)

Neurodevelopmental DisordersMental DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsSuicideSelf-Injurious BehaviorBehavioral SymptomsBehavior

Study Officials

  • Lisa M Horowitz, Ph.D.

    National Institute of Mental Health (NIMH)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 24, 2012

First Posted

January 25, 2012

Study Start

January 6, 2012

Primary Completion

September 13, 2019

Study Completion

September 13, 2019

Last Updated

September 18, 2019

Record last verified: 2019-09

Locations